Publications | Lund University Publications

1 – 10 of 14

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Bosch%2C+Ana%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Bosch%2C+Ana%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2024
Mark Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
Godina, Christopher ^LU ; Belting, Mattias ^LU ; Vallon-Christersson, Johan ^LU ; Isaksson, Karolin ^LU ; Bosch, Ana ^LU and Jernström, Helena ^LU (2024) In Scientific Reports 14(1).
- Contribution to journal › Article
Mark High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher ^LU ; Khazaei, Somayeh ^LU ; Belting, Mattias ^LU ; Vallon-Christersson, Johan ^LU ; Nodin, Björn ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU ; Bosch, Ana ^LU and Jernström, Helena ^LU (2024) In PLoS ONE 19(7). p.1-21
- Contribution to journal › Article
2023
Mark Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
Godina, Christopher ^LU ; Tryggvadottir, Helga ^LU ; Bosch, Ana ^LU ; Borgquist, Signe ^LU ; Belting, Mattias ^LU ; Isaksson, Karolin ^LU and Jernström, Helena ^LU (2023) In Breast Cancer Research and Treatment 199(2). p.335-347
- Contribution to journal › Article
Mark Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
Sigurjonsdottir, Gudbjörg ^LU ; De Marchi, Tommaso ^LU ; Ehinger, Anna ^LU ; Hartman, Johan ; Bosch, Ana ^LU ; Staaf, Johan ^LU ; Killander, Fredrika ^LU and Niméus, Emma ^LU (2023) In Breast Cancer Research 25(1).
- Contribution to journal › Article
Mark The Lucerne Toolbox 2 to optimise axillary management for early breast cancer : a multidisciplinary expert consensus
Kaidar-Person, Orit ; Pfob, André ; Gentilini, Oreste Davide ; Borisch, Bettina ; Bosch, Ana ^LU ; Cardoso, Maria João ; Curigliano, Giuseppe ; De Boniface, Jana ; Denkert, Carsten and Hauser, Nik , et al. (2023) In EClinicalMedicine 61.
- Contribution to journal › Scientific review
2022
Mark Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
Godina, Christopher ^LU ; Indira Chandran, Vineesh ^LU ; Barbachowska, Magdalena ^LU ; Tryggvadottir, Helga ^LU ; Nodin, Björn ^LU ; Visse, Edward ^LU ; Borgquist, Signe ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU and Bosch, Ana ^LU , et al. (2022) In Translational Oncology 22.
- Contribution to journal › Article
2021
Mark Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
Godina, Christopher ^LU ; Khazaei, Somayeh ^LU ; Tryggvadottir, Helga ^LU ; Visse, Edward ^LU ; Nodin, Björn ^LU ; Jirström, Karin ^LU ; Borgquist, Signe ^LU ; Bosch, Ana ^LU ; Isaksson, Karolin ^LU and Jernström, Helena ^LU (2021) In Carcinogenesis 42(11). p.1314-1325
- Contribution to journal › Article
Mark Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
Alves, Carla L. ; Ehmsen, Sidse ; Terp, Mikkel G. ; Portman, Neil ; Tuttolomondo, Martina ; Gammelgaard, Odd L. ; Hundebøl, Monique F. ; Kaminska, Kamila ^LU ; Johansen, Lene E. and Bak, Martin , et al. (2021) In Nature Communications 12(1).
- Contribution to journal › Article
Mark Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila ^LU ; Akrap, Nina ^LU ; Staaf, Johan ^LU ; Alves, Carla L ; Ehinger, Anna ^LU ; Ebbesson, Anna ^LU ; Hedenfalk, Ingrid ^LU ; Beumers, Lukas ^LU ; Veerla, Srinivas ^LU and Harbst, Katja ^LU , et al. (2021) In Breast cancer research : BCR 23(1). p.26-26
- Contribution to journal › Article
Mark Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients with ERBB2-Positive Breast Cancer : A Phase 2 Randomized Clinical Trial
Hatschek, Thomas ; Foukakis, Theodoros ; Bjöhle, Judith ; Lekberg, Tobias ; Fredholm, Hanna ; Elinder, Ellinor ; Bosch, Ana ; Pekar, Gyula ^LU ; Lindman, Henrik and Schiza, Aglaia , et al. (2021) In JAMA Oncology 7(9). p.1360-1367
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove author: Bosch, Ana